Cyclooxygenase-2 Expression Is a Predictive Marker for Late Recurrence in Colorectal Cancer

Introduction. Cyclooxygenase-2 (COX-2) expression is elevated in colorectal cancer (CRC). However, data about the relation between COX-2 expression and the impact on the biologic behavior of recurrent disease are inconclusive as yet. The aim of this study is to investigate the relationship between t...

Full description

Saved in:
Bibliographic Details
Main Authors: Sung Hoo Kim, Byung Kyu Ahn, Seung Sam Paik, Kang Hong Lee
Format: Article
Language:English
Published: Wiley 2018-01-01
Series:Gastroenterology Research and Practice
Online Access:http://dx.doi.org/10.1155/2018/7968149
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832555895611981824
author Sung Hoo Kim
Byung Kyu Ahn
Seung Sam Paik
Kang Hong Lee
author_facet Sung Hoo Kim
Byung Kyu Ahn
Seung Sam Paik
Kang Hong Lee
author_sort Sung Hoo Kim
collection DOAJ
description Introduction. Cyclooxygenase-2 (COX-2) expression is elevated in colorectal cancer (CRC). However, data about the relation between COX-2 expression and the impact on the biologic behavior of recurrent disease are inconclusive as yet. The aim of this study is to investigate the relationship between the status of COX-2 expression in the primary CRC and the characteristics of recurrence after curative resection of stage I to III CRC. Materials and Methods. Ninety-eight patients with recurrence in 376 CRC patients, who underwent curative surgery between January 1991 and August 2001, were retrospectively assessed. Immunohistochemical staining, performed for the presence of COX-2 on tissue microarrays, was analyzed. Results. Forty-six patients showed elevated COX-2 expression, and 52 patients did not. The mean time to recurrence was significantly longer in the positive group than in the negative group (34.1 months ± 30.0 versus 21.9 months ± 17.4; P=0.019). Positive COX-2 expression was correlated with late recurrence (>3 years after surgery) [43.5% versus 13.5%; P=0.001]. In multivariate analysis, COX-2 expression was an independent factor associated with late recurrence (OR 4.656; 95% CI, 1.696 to 12.779; P=0.003). Recurrence pattern and postrecurrence survival were not different between the two groups. Conclusions. Elevated COX-2 expression in itself is not a prognostic factor, but COX-2 expression in tumor tissue may be an independent predictive marker of late recurrence for patients with stage I to III CRC.
format Article
id doaj-art-f790695f048647e4991d919061d8e126
institution Kabale University
issn 1687-6121
1687-630X
language English
publishDate 2018-01-01
publisher Wiley
record_format Article
series Gastroenterology Research and Practice
spelling doaj-art-f790695f048647e4991d919061d8e1262025-02-03T05:46:56ZengWileyGastroenterology Research and Practice1687-61211687-630X2018-01-01201810.1155/2018/79681497968149Cyclooxygenase-2 Expression Is a Predictive Marker for Late Recurrence in Colorectal CancerSung Hoo Kim0Byung Kyu Ahn1Seung Sam Paik2Kang Hong Lee3Department of Surgery, Hanyang University College of Medicine, Seoul, Republic of KoreaDepartment of Surgery, Hanyang University College of Medicine, Seoul, Republic of KoreaDepartment of Pathology, Hanyang University College of Medicine, Seoul, Republic of KoreaDepartment of Surgery, Hanyang University College of Medicine, Seoul, Republic of KoreaIntroduction. Cyclooxygenase-2 (COX-2) expression is elevated in colorectal cancer (CRC). However, data about the relation between COX-2 expression and the impact on the biologic behavior of recurrent disease are inconclusive as yet. The aim of this study is to investigate the relationship between the status of COX-2 expression in the primary CRC and the characteristics of recurrence after curative resection of stage I to III CRC. Materials and Methods. Ninety-eight patients with recurrence in 376 CRC patients, who underwent curative surgery between January 1991 and August 2001, were retrospectively assessed. Immunohistochemical staining, performed for the presence of COX-2 on tissue microarrays, was analyzed. Results. Forty-six patients showed elevated COX-2 expression, and 52 patients did not. The mean time to recurrence was significantly longer in the positive group than in the negative group (34.1 months ± 30.0 versus 21.9 months ± 17.4; P=0.019). Positive COX-2 expression was correlated with late recurrence (>3 years after surgery) [43.5% versus 13.5%; P=0.001]. In multivariate analysis, COX-2 expression was an independent factor associated with late recurrence (OR 4.656; 95% CI, 1.696 to 12.779; P=0.003). Recurrence pattern and postrecurrence survival were not different between the two groups. Conclusions. Elevated COX-2 expression in itself is not a prognostic factor, but COX-2 expression in tumor tissue may be an independent predictive marker of late recurrence for patients with stage I to III CRC.http://dx.doi.org/10.1155/2018/7968149
spellingShingle Sung Hoo Kim
Byung Kyu Ahn
Seung Sam Paik
Kang Hong Lee
Cyclooxygenase-2 Expression Is a Predictive Marker for Late Recurrence in Colorectal Cancer
Gastroenterology Research and Practice
title Cyclooxygenase-2 Expression Is a Predictive Marker for Late Recurrence in Colorectal Cancer
title_full Cyclooxygenase-2 Expression Is a Predictive Marker for Late Recurrence in Colorectal Cancer
title_fullStr Cyclooxygenase-2 Expression Is a Predictive Marker for Late Recurrence in Colorectal Cancer
title_full_unstemmed Cyclooxygenase-2 Expression Is a Predictive Marker for Late Recurrence in Colorectal Cancer
title_short Cyclooxygenase-2 Expression Is a Predictive Marker for Late Recurrence in Colorectal Cancer
title_sort cyclooxygenase 2 expression is a predictive marker for late recurrence in colorectal cancer
url http://dx.doi.org/10.1155/2018/7968149
work_keys_str_mv AT sunghookim cyclooxygenase2expressionisapredictivemarkerforlaterecurrenceincolorectalcancer
AT byungkyuahn cyclooxygenase2expressionisapredictivemarkerforlaterecurrenceincolorectalcancer
AT seungsampaik cyclooxygenase2expressionisapredictivemarkerforlaterecurrenceincolorectalcancer
AT kanghonglee cyclooxygenase2expressionisapredictivemarkerforlaterecurrenceincolorectalcancer